Compare AU
Compare IXJ vs. IZZ
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the iShares Global Healthcare ETF (IXJ) and the iShares China Large-Cap ETF (IZZ). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
IXJ | IZZ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 241 | 32 |
Median incremental investment | $1,000.00 | $2,600.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,671.24 | $3,912.20 |
Average age group | 26 - 35 | > 35 |
Key Summary
IXJ | IZZ | |
|---|---|---|
Strategy | IXJ.AX was created on 2001-11-13 by iShares. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with the performance of an index, before fees and expenses. The index is designed to measure the performance of global biotechnology, healthcare, medical equipment and pharmaceuticals companies and may include large-, mid- or smallcapitalisation stocks | IZZ.AX was created on 2004-10-05 by iShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to provide investors with the performance of the FTSE China 50 Index, before fees and expenses. The index is designed to measure the performance of 50 of the largest and most liquid Chinese companies which trade on the Hong Kong Stock Exchange |
Top 3 holdings | Eli Lilly and Company (8.25 %) UnitedHealth Group Incorporated (5.81 %) Johnson & Johnson (4.72 %) | MEITUAN (10.47 %) ALIBABA GROUP HOLDING LTD (8.86 %) TENCENT HOLDINGS LTD (8.29 %) |
Top 3 industries | Other (99.98 %) Communication Services (0.02 %) | Other (58.33 %) Consumer Discretionary (21.66 %) Communication Services (10.44 %) |
Top 3 countries | United States (99.97 %) | China (100.00 %) |
Management fee | 0.46 % | 0.74 % |
Key Summary
IXJ | IZZ | |
|---|---|---|
Issuer | iShares | iShares |
Tracking index | S&P Global 1200 Healthcare Sector Index - AUD | FTSE China 50 Net Tax USD Index |
Asset class | ETF | ETF |
Management fee | 0.46 % | 0.74 % |
Price | $139.27 | $50.48 |
Size | $1.373 billion | $306.510 million |
10Y return | 123.73 % | -1.41 % |
Annual distribution yield (5Y) | 1.26 % | 1.97 % |
Market | ASX | ASX |
First listed date | 11/03/2009 | 15/11/2007 |
Purchase fee | $6.50 | $6.50 |
Community Stats
IXJ | IZZ | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 241 | 32 |
Median incremental investment | $1,000.00 | $2,600.00 |
Median investment frequency | Monthly | Monthly |
Median total investment | $1,671.24 | $3,912.20 |
Average age group | 26 - 35 | > 35 |
Pros and Cons
IXJ | IZZ | |
|---|---|---|
Pros |
|
|
Cons |
|
|
IXJ | IZZ |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |